Experimental work shows that subretinal fluid is removed both by active transport across the retinal pigment epithelium (RPE) and by passive hydrostatic and oncotic forces that work most effectively when the RPE barrier has been damaged. The re tina will stay attached whether or not the RPE is intact-but retinal function requires the RPE barrier and thus active transport is the primary mechanism of sub retinal fluid control. RPE fluid transport is normally limited by the retina (which resists water flow from the vitreous) but can be. quite powerful when a reservoir of subretinal fluid is present.
Summary
Experimental work shows that subretinal fluid is removed both by active transport across the retinal pigment epithelium (RPE) and by passive hydrostatic and oncotic forces that work most effectively when the RPE barrier has been damaged. The re tina will stay attached whether or not the RPE is intact-but retinal function requires the RPE barrier and thus active transport is the primary mechanism of sub retinal fluid control. RPE fluid transport is normally limited by the retina (which resists water flow from the vitreous) but can be. quite powerful when a reservoir of subretinal fluid is present.
Clinical serous detachments are unlikely to form solely as a result of small RPE defects or leaks, since the active and passive transport systems for removing subre tinal fluid are both so strong. It is suggested that the primary pathology in most serous retinopathy is a diffuse metabolic or vascular abnormality ofRPE fluid trans port, and that RPE defects or leaks are necessary but only secondary components of the disease. Several hypotheses for removing subretinal fluid therapeutically are considered in terms of their physiology.
The subretinal space between the photoreceptors and the retinal pigment epi thelium (RPE) is the remnant of the embryonic optic vesicle. In the developed eye the subretinal space is of minimal size, but no tissue junctions form across it and it can re-open under pathological conditions of retinal detachment. In a sense, the title of this paper is misleading since normally there should be no subretinal fluid to control.
However, ocular mechanisms are necessary to prevent an accumulation of fluid, and to remove it under conditions of stress or disease.
Experimental background
Active water trampart across the RPE The RPE is a transporting epithelium which moves not only ions and metabolites, but also a net volume of water in an apical-to-basal tieally-active large moleculesY On the other band, sucrose solution is not absorbed until ions begin to diffuse into it. 6 , 1 0 The absorption of small experimental detachments is also �peded by generalised metabolic inhibition from anoxia, cyanide or dinitrophenol. 5 , 1 0 , 11 , Inhibition of the sodium-potassium pump with ouabain, interestingly, appears to enhance the absorption of subretinal fluid. 5 This makes sense, insofar as the sodium pump is only located on the apical side of the RPE JIld produces a net movement of sodium into the subretinal space. The carbonic anhydrase inhibitor, acetazolamide, also enhances the Jabsorption of subretinal fluid by a mechanism yet to be determined.5 , 12 The effect has not been duplicated by modifying blood/gas para meters, and appears to involve a direct action of the drug upon the RPE. Rather high doses are required in the rabbit, but lower doses seem useful in primates13 and this effect may underlie the recent use of carbonic anhydrase inhibitors to treat cystoid macular oedema. 14 Subretinal fluid absorption is reduced by exposure to cyclic AMP,15 , 16 which apparently facilitates apical sodium and chloride trans port and reduces the net movement of ions out of the eye.1 7 Cyclic GMP has a mild facili tatory effect with both subretinal saline and eerum.15.16 The involvement of cyclic nucleo tides with water transport may explain why adrenalin appears to influence the formation or removal of fluid, in experimentall8 or clini cal serous chorioretinopathy. 19 The magnitude of fluid movement across the RPE can be quite substantial. By injecting ftuid into the subretinal space of rabbits, we estimated the rate of RPE water transport to be 0.12-0.31 ul/mm2/hr.6 , 1 0 In vivo studies by others have shown rates of .064 in dogs3 and .073 in monkeys. 2 0 These rates would produce bulk flow out of the eye within the same order of magnitude as the flow of aqueous. 21 Some readers may discern a paradox in this last observation. If the RPE transports fluid at a rate comparable to the secretion of aqueous, how then is intraocular pressure maintained pd what is the role for the trabecular mesh work? If the RPE routinely transported fluid at its maximum rate, the inconsistencies would hold, but my guess is that ongoing fluid transport across the normal RPE is actually very small: the rates quoted above represent RPE transport with an unlimited reservoir of fluid, but there is normally little fluid in the subretinal space. The retina provides substan tial resistance to fluid flow,22 and only a small amount of fluid percolates through in response to intraocular pressure. In other words, the rate-limiting step is ordinarily the passage of fluid through the retina rather than the RPE. When there is a detachment, how ever, the RPE can transport fluid at its maxi mal rate (e.g. we know from clinical experience that large amounts of subretinal fluid can absorb within 24 hours after place ment of a scleral buckle).23
Passive water transport mechanisms
Although the presence of tight junctions between the RPE cells limits the passive movements of fluid across the RPE, subret inal fluid does respond modestly to hydro static or osmotic pressure. Both saline fluid and serum in the subretinal space is absorbed slightly faster when the intraocular pressure is raised from 16mm to 38mm Hg, and the absorption is prolonged when the pressure is reduced to zero.24 Absorption is hastened by intravenous injections of mannitol, which raise the choroidal osmotic pressure25 (although this procedure may also alter RPE permeability). 26 Although an elevated chor oidal osmotic pressure may be expected to draw subretinal fluid into the choroid, the mechanisms by which hydrostatic pressure enhances subretinal fluid absorption are less clear. An elevated head of intraocular pres sure will drive more fluid per unit time through the semipermeable retina, but this does not easily explain why fluid under the ret ina should be selectively absorbed. Because of its resistance to flow, the retina may act, under the influence of intraocular pressure, as a tamponade to push out subretinal fluid. 2 7 , 28
Role of the RP E barrier
There is a tendency for clinicians to view the RPE as a barrier that protects the subretinal space from an influx of choroidal fluid. Experimental evidence, however, indicates exactly the opposite: subretinal fluid is cleared fa ster than normal when the barrier has been damaged. For example, saline fluid injected into the subretinal space will absorb more quickly over a cluster of laser burns than over normal RPE,29 and will absorb even faster if the pigment epithelium has been dif fusely damaged with sodium iodate.
These data tell us that small (or even large) defects in the RPE barrier do not by them selves cause subretinal fluid to accumulate or produce serous detachment. 32 In fact, the loss of barrier will tend to cause an egress of fluid (a concept that may be part of the effect of photocoagulation in clearing retinal oedema). Is the RPE needed for retinal attachment?33Jt is not if retinal attachment is all that one requires of the RPE. 34 However, the RPE also controls the metabolic environment of the photoreceptors, phagocytises outer segment debris, and participates in the visual pigment regeneration cycle. Thus, retina may stay attached without the RPE, but it cannot sur vive functionally. In order to maintain photo receptor function we require an RPE barrier-and since that barrier blocks the effectiveness of passive fluid transport systems, we must use active transport to move fluid across the RPE.
Clinical implications

Normal retinal apposition:
We have seen that the mechanisms of fluid transport across the RPE represent powerful forces to keep the retina in place. In conjunc tion with other adhesive mechanisms within the subretinal space,28 passive forces work to keep the retina apposed, and active transport keeps the subretinal space dehydrated. Clini cal detachments are relatively infrequent events that usually (with the exception of a few syndromes such as central serous chori oretinopathy) involve rather severe pathol ogy such as marked choroidal ischaemia or traction from the vitreous. It is hard to under stand how a small volume of fluid leaking through a pinpoint RPE defect can over whelm both the active and passive control mechanisms of the surrounding RPE to pro duce serous detachment. Some hypotheses about the conditions under which this might occur are considered befow.28,32
Mechanisms of serous detachment
The mere presence of a RPE defect or 'leak' is unlikely to be sufficient to create serous detachment. Clearly, a site of fluid entry is necessary, but the experimental and clinical data that have been presented argue strongly that focal defects alone..-will not produce detachment (and indeed may enhance fluid removal). Clinical experience tells us that ordinary laser burns do not cause serous detachments. We have found it exceedingly difficult to create serous detachments in ani mals, even by producing hypotony or chor oidal congestion in combination with focal laser burns and cyclic AMP administration. 35 How, then, does serous fluid form? On the oretical grounds one must have (1) a site of fluid entry; (2) a source of fluid pressure;
(3) an inability of the surrounding RPE to remove fluid; and possibly (4) weakened re tinal adhesion so that fluid can spread within the subretinal space. These conditions are met in some drastic pathologic states such as total blockage of choridal venous drainage, but a more subtle balance of factors must be present if we are to explain conditions like central serous chori oretinopathy. When the volume of fluid enter ing a serous detachment is relatively small, as it must be through a focal RPE defect, then the RPE must be unable (actively or pass ively) to remove the fluid effectively. This sug gests that the underlying RPE barrier is largely intact (or passive fluid egress would occur), but that RPE transport mechanisms are compromised (or the fluid would leave actively). For these reasons, I have pro posed32 that central serous chorioretinopathy and other serous retinopathies represent dif fuse disorders of RPE fluid transport rather than disorders of a small leakage site. The leakage site may be necessary, but it is not suf ficient, and it may only represent an incidental complication of underlying metabolic or vas cular disease involving the RPE and/or choroid.
This concept is consistent with evidence that central serous chorioretinopathy occurs in young men under stress,19 and can be mimicked experimentally with chronic adren alin injections.18 It is also consistent with the occurrence of serous detachments in systemic vascular diseases. Laser therapy may hasten the removal of fluid by sealing the immediate leak,8 but recurrences will be likely (and occur clinically) unless the underlying metabolic/ vascular abnormality (e.g. the stress response) is relieved. Ultimately to under stand the pathogenesis of these diseases, and cure them, our attentions should ideally be focussed on the diffuse RPE transport abnormality rather than the angiographic 'leak'.
Theoretical strategies fo r enhancing sub retinal fluid removal:
The removal of subretinal fluid could be stimulated, in theory, by either enhancement of active transport systems, enhancement of passive transport forces, or modification of the RPE barrier.
RPE active transport might in theory be enhanced by accelerating general metabolism (e.g. with hyperbaric oxygen) although there is no experimental evidence that this works. Optimising environmental conditions such as blood pH or temperature might also favour active transport. Evidence has been pre sented already that acetazolamides,12 and cyclic GMpIS , 16 do facilitate transport, and acetazolamide is in fact being used for the treatment of cystoid macular oedema.14 There is dispute whether acetazolamide acts primar ily on the pigment epithelium or on the retinal capillaries,36 and the drug has not been proven to be of any value in central serous retino pathy. However, carbonic anhydrase inhibi tors may eventually have a role in hastening the' absorption of subretinal fluid or preven ting the development or spread of retinal detachment.
Passive forces can also be modified to alter subretinal fluid movement. Choroidal conges tion and serous detachment are complications of severe hypotony; conversely, the cautious elevation of intraocular pressure might be useful in treating certain types of subretinal fluid accumulation. Intravenous mannitofS or similar osmotic agents should help to draw out subretinal fluid, and could be valuable clini cally under conditions where the dehydration of the subretinal space would be maintained after the fluid load was removed. The amount of fluid entering the subretinal space from the vitreous is normally very small, so that once a large subretinal fluid load has been dissipated, even a compromised RPE may be able to maintain retinal apposition. The role of barrier damage in causing or treating detachment is complex. The RPE is obviously damaged by photocoagulation, which does not ordinarily cause detachments, but laser burns also destroy the choriocapilla ris which might be needed as a source or sink of fluid. Photocoagulation effects are generally transient, insofar as new RPE cells will cover a laser burn scar within 10 to 14 days.8 Macular photocoagulation grids are used clinically to remove diffuse retinal oedema3? (which is different, of course, from subretinal fluid), but the beneficial effects may not appear for weeks or months which suggests that the mechanism is not merely an opening of passive egress channels. Neverthe less, there may be situations in which a tran sient opening of passive RPE 'pores' would be of clinical value, especially if laser or other techniques can be evolved to damage the RPE barrier without destroying the choricapillaris. 
